The Efficacy And Safety Of Butrans (buprenorphine) Transdermal System In Opioid-Naive Patients With Moderate To Severe Low Back Pain

This entry was posted by on Sunday, 27 March, 2011 at

Physicians from Purdue Pharma LP, Stamford, CT, showcased study results that demonstrate the analgesic efficacy and safety of Butrans for the relief of moderate to severe chronic low back pain in opioid-naive patients. Butrans is a transdermal delivery system that provides systemic delivery of buprenorphine, a Schedule III medication, continuously over a 7-day period. “Butrans is a new treatment for chronic pain that was approved [by the Food and Drug Administration] on June 30, 2010, and is available in the market today,” said Deborah Steiner, MD, MS, medical director at Purdue Pharma… (Source: Health News from Medical News Today)

MedWorm Sponsor Message: Watch the new MedWorm demo and find out how to get all the very latest, relevant, organized information daily!

Via: MedWorm: Back Pain

Tags: , , ,
Category: Health
You can follow any responses to this entry via RSS.
Comments are currently closed, but you can trackback from your own site.

Comments are closed.